Mediterranean Diet and Weight Loss: Targeting the Bile Acid/Gut Microbiome Axis to Reduce Colorectal Cancer Risk
Mediterranean Diet and Weight Loss: Targeting the Bile Acid/Gut Microbiome Axis to Reduce Colorectal Cancer Risk
批准号:
10543452
负责人:
Marian L. Fitzgibbon
金额:
$62.86万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
未结题
起止时间:
2021-01-15 至 2025-12-31
关键词:
AcidsAddressAdherenceAdultAffectAfricanAfrican American populationAmino AcidsAnimalsAntineoplastic AgentsBacteriaBile AcidsBilophila wadsworthiaBiometryBody Weight decreasedButyratesCaloric RestrictionCaloriesCell ProliferationCellsCellular biologyClinical ResearchClostridiumColonColorectal CancerComputational BiologyControlled StudyCoupledDNA RepairDataDeoxycholic AcidDevelopmentDietDietary FactorsDietary FiberDietary PracticesDisparityEpithelial CellsExhibitsFiberFosteringGene ExpressionGenesGenomic InstabilityGlycineGrowthHigh PrevalenceHumanHydrogen SulfideIncidenceInflammationIntakeInterventionIntestinesLinkMediatingMedicalMedicineMediterranean DietMetabolicMetabolismMicrobiologyMolecularMucositisNot Hispanic or LatinoObesityObservational StudyPathway interactionsPatternPersonsPhysiologyPlantsPrimatesProductionProliferatingProteinsPsychologyPublic HealthRaceRandomizedRisk FactorsRisk ReductionSamplingStructureSubgroupTaurineTestingTranslatingTumor PromotersTumor PromotionWeightWeight maintenance regimenanti-cancerarmbile acid metabolismcancer health disparitycarcinogenesiscolon bacteriacolorectal cancer preventioncolorectal cancer riskdietary restrictionevidence basegenotoxicitygut bacteriagut microbesgut microbiomegut microbiotahigh risk populationinnovationintervention effectintestinal epitheliumlifestyle interventionmicrobialmicrobial compositionmodifiable riskmortalitymultidisciplinarynutritionpersonalized approachpost interventionresponsesaturated fat
中文摘要
摘要。结直肠癌(CRC)与多种风险因素相关,包括肥胖、低纤维饮食,
以及高动物蛋白和饱和脂肪(SFat)的饮食。非裔美国人(AAs)的患病率较高,
这些风险因素,他们有最高的发病率CRC和相关死亡率。这些多重风险因素
也与较高的循环和粪便胆汁酸(BA)以及BA氨基酸结合从甘氨酸的转移有关
牛磺酸这些与BA相关的变化可以改变肠道的组成、结构和代谢活性
微生物群,促进肠道细菌扩张和代谢牛磺酸结合的BA的条件,以遗传毒性
硫化氢(H2S)和肿瘤促进剂脱氧胆酸(DCA);结肠环境有助于
CRC的形成。我们已经表明,在海洋中,产生H2S的细菌的丰度明显较高,
与非西班牙裔白人相比,AA的结肠是AA CRC病例的定义特征,
细菌作为CRC发展的贡献者,以种族依赖的方式。此外,微生物的差异
与AAs中较高的SFat和动物蛋白摄入量相关,提供了关键的干预目标。我们
假设靶向BA-肠道微生物组轴以抑制微生物的丰度、生长和代谢活性,
通过饮食和减肥(WL)产生H2S和DCA的细菌可能会降低CRC风险,尤其是在
原子吸收法地中海饮食(MedDiet)是一种主要以植物为基础的饮食模式,与CRC预防相关,
在观察性研究中,微生物产生抗癌代谢物。MedDiet可以改变BA代谢,
在灵长类动物中显示,并且当与卡路里限制结合时,在以下方面显示出优越的上级依从性和体重控制:
人类,因为它的美味。到目前为止,没有研究在RCT中测试单独的MedDiet(Med-Diet)的效果。
A),WL通过生活方式干预(WL-A)或热量限制的MedDiet用于WL(WL-Med)对BA-肠道
微生物组轴及其与AA中CRC预防的相关性。我们的多学科团队
心理学、营养学、微生物学、分子细胞生物学、计算生物学、医学和
生物统计学,建议进行一项四臂随机对照试验,其中200名45-75岁的肥胖AA完成其中一项
8个月干预后:Med-A,体重稳定; WL-A,热量限制,无饮食模式改变; WL-
Med;或Control。我们将使用在基线、研究中期(4个月)和干预后收集的样本和数据
比较干预措施对1)循环和粪便BA的浓度和组成; 2)
肠道微生物群和代谢功能;和3)脱落的肠上皮细胞的基因表达谱。
我们的方法是强大的,因为我们的多学科团队,使用基于证据的生活方式干预,
复杂的组学分析,以检查饮食/WL,肠道微生物组和宿主肠道之间的串扰
physiology.如果成功,这项研究可能对AA和其他癌症患者的CRC风险产生深远的公共卫生影响。
高风险人群,这将转化为及时传播的机会。
英文摘要
ABSTRACT. Colorectal cancer (CRC) is associated with multiple risk factors including, obesity, low fiber diets,
and diets high in animal protein and saturated fat (SFat). African Americans (AAs) have a higher prevalence of
these risk factors and they have the highest incidence of CRC and related mortality. These multiple risk factors
are also linked to higher circulating and fecal bile acids (BA) and a shift in BA amino acid conjugation from glycine
to taurine. These BA-related changes can alter the composition, structure, and metabolic activity of the gut
microbiota, fostering conditions for gut bacteria to expand and metabolize taurine-conjugated BAs to genotoxic
hydrogen sulfide (H2S) and the tumor promoter, deoxycholic acid (DCA); a colonic milieu conducive to the
formation of CRC. We have shown that the abundance of H2S-producing bacteria is significantly higher in the
colon of AAs compared to non-Hispanic whites and is a defining feature among AA CRC cases implicating these
bacteria as contributors to CRC development in a race-dependent manner. Moreover, the microbial difference
is associated with higher intake of SFat and animal protein in AAs, providing a pivotal intervention target. We
hypothesize that targeting the BA-gut microbiome axis to suppress abundance, growth and metabolic activity of
H2S and DCA producing bacteria through diet and weight loss (WL) may reduce CRC risk, especially among
AAs. A Mediterranean Diet (MedDiet), a largely plant-based dietary pattern, is relevant to CRC prevention and
microbial production of anti-cancer metabolites in observational studies. A MedDiet can shift BA metabolism as
shown in primates and when combined with calorie restriction, shows superior adherence and weight control in
humans, given its palatability. To date, no studies have tested in an RCT the effects of a MedDiet alone (Med-
A), WL through lifestyle intervention (WL-A) or a calorie-restricted MedDiet for WL (WL-Med) on the BA-gut
microbiome axis and its relevance to CRC prevention among AAs. Our multidisciplinary team combining
expertise in psychology, nutrition, microbiology, molecular cell biology, computational biology, medicine and
biostatistics, propose to conduct a four-arm RCT in which 200 obese AAs, 45-75 years old complete one of the
following 8-month interventions: Med-A, weight stable; WL-A, calorie restriction with no diet pattern change; WL-
Med; or Control. We will use samples and data collected at baseline, mid-study (month-4) and post-intervention
to compare the effects of the interventions on 1) Concentration and composition of circulating and fecal BAs; 2)
Gut microbiota and metabolic function; and 3) Gene expression profiles of exfoliated intestinal epithelial cells.
Our approach is strong given our multidisciplinary team, use of evidence-based lifestyle interventions, and
sophisticated –omics analyses to examine crosstalk between diet/WL, gut microbiome, and host intestinal
physiology. If successful, this study could have profound public health impact on CRC risk among AAs and other
high-risk populations, that would translate into timely dissemination opportunities.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mediterranean Diet and Weight Loss: Targeting the Bile Acid/Gut Microbiome Axis to Reduce Colorectal Cancer Risk
-
批准号:10328968
-
项目类别:
-
资助金额:$64.08万
-
财政年份:2021
-
负责人:Marian L. Fitzgibbon
-
依托单位:
Mediterranean Diet and Weight Loss: Targeting the Bile Acid/Gut Microbiome Axis to Reduce Colorectal Cancer Risk
-
批准号:10117630
-
项目类别:
-
资助金额:$66.93万
-
财政年份:2021
-
负责人:Marian L. Fitzgibbon
-
依托单位:
Mediterranean Diet, Weight Loss, and Cognition in Obese Older Adults
-
批准号:9921480
-
项目类别:
-
资助金额:$73.53万
-
财政年份:2016
-
负责人:Marian L. Fitzgibbon
-
依托单位:
Mediterranean Diet, Weight Loss, and Cognition in Obese Older Adults
-
批准号:9302828
-
项目类别:
-
资助金额:$77.12万
-
财政年份:2016
-
负责人:Marian L. Fitzgibbon
-
依托单位:
Society of Behavioral Medicine 2016 Annual Meeting & Scientific Sessions
-
批准号:9121875
-
项目类别:
-
资助金额:$6.0万
-
财政年份:2016
-
负责人:Marian L. Fitzgibbon
-
依托单位:
Mediterranean Diet, Weight Loss, and Cognition in Obese Older Adults
-
批准号:9115315
-
项目类别:
-
资助金额:$80.6万
-
财政年份:2016
-
负责人:Marian L. Fitzgibbon
-
依托单位:
Administrative Core
-
批准号:10267705
-
项目类别:
-
资助金额:$59.91万
-
财政年份:2015
-
负责人:Marian L. Fitzgibbon
-
依托单位:
Administrative Core
-
批准号:10473812
-
项目类别:
-
资助金额:$58.76万
-
财政年份:2015
-
负责人:Marian L. Fitzgibbon
-
依托单位:
Administrative Core
-
批准号:10082851
-
项目类别:
-
资助金额:$60.79万
-
财政年份:2015
-
负责人:Marian L. Fitzgibbon
-
依托单位:
Comparative Effectiveness of Customary Fit and Strong! vs. Fit and Strong! Plus
-
批准号:8484329
-
项目类别:
-
资助金额:$58.68万
-
财政年份:2012
-
负责人:Marian L. Fitzgibbon
-
依托单位:
Comparative Effectiveness of Customary Fit and Strong! vs. Fit and Strong! Plus
-
批准号:8295600
-
项目类别:
-
资助金额:$61.8万
-
财政年份:2012
-
负责人:Marian L. Fitzgibbon
-
依托单位:
Comparative Effectiveness of Customary Fit and Strong! vs. Fit and Strong! Plus
-
批准号:8664326
-
项目类别:
-
资助金额:$59.77万
-
财政年份:2012
-
负责人:Marian L. Fitzgibbon
-
依托单位:
Evaluating Economic Subsidies To Improve Dietary Intake Among Low Income Families
-
批准号:7829696
-
项目类别:
-
资助金额:$49.54万
-
财政年份:2009
-
负责人:Marian L. Fitzgibbon
-
依托单位:
Evaluating Economic Subsidies To Improve Dietary Intake Among Low Income Families
-
批准号:7941953
-
项目类别:
-
资助金额:$49.69万
-
财政年份:2009
-
负责人:Marian L. Fitzgibbon
-
依托单位:
Family Based Obesity Prevention in Latino Families
-
批准号:7252166
-
项目类别:
-
资助金额:$19.41万
-
财政年份:2007
-
负责人:Marian L. Fitzgibbon
-
依托单位:
Family Based Obesity Prevention in Latino Families
-
批准号:7394966
-
项目类别:
-
资助金额:$15.93万
-
财政年份:2007
-
负责人:Marian L. Fitzgibbon
-
依托单位:
Preschool Based Obesity Prevention Effectiveness Trial
-
批准号:6961499
-
项目类别:
-
资助金额:$74.1万
-
财政年份:2005
-
负责人:Marian L. Fitzgibbon
-
依托单位:
Preschool Based Obesity Prevention Effectiveness Trial
-
批准号:7122088
-
项目类别:
-
资助金额:$70.91万
-
财政年份:2005
-
负责人:Marian L. Fitzgibbon
-
依托单位:
Preschool Based Obesity Prevention Effectiveness Trial
-
批准号:7238011
-
项目类别:
-
资助金额:$58.01万
-
财政年份:2005
-
负责人:Marian L. Fitzgibbon
-
依托单位:
Preschool Based Obesity Prevention Effectiveness Trial
-
批准号:7435333
-
项目类别:
-
资助金额:$35.46万
-
财政年份:2005
-
负责人:Marian L. Fitzgibbon
-
依托单位:
海外基金